Variables | TB/HIV co-infected patients (n = 97) | HIV-infected patients without TB (n = 455) | P-Value |
---|---|---|---|
Age in years, Mean (SD) | 34.5 (9.5) | 33.4 (8.1) | 0.2 |
Sex | |||
Male | 43 (44.3%) | 185 (40.6%) | 0.5 |
Female | 54 (55.7%) | 270 (59.4%) | |
Employment | |||
Unemployed | 7 (7.2%) | 52 (11.4%) | 0.2 |
Employed | 90 (92.8%) | 403 (88.6%) | |
Have income source | |||
Yes | 69 (71.1%) | 316 (69.5%) | 0.7 |
No | 28 (28.9%) | 139 (30.5%) | |
Have social support | |||
Yes | 11(11.3%) | 63 (13.8%) | 0.5 |
No | 86 (87.7%) | 392 (86.2%) | |
WHO staging | |||
Stage I | - | 71(15.6%) | 0.000 |
Stage II | - | 64 (14.1%) | |
Stage III | 79 (81.4) | 216 (47.5%) | |
Stage IV | 18 (18.6%) | 65 (14.2%) | |
Mean CD4 lymphocyte count, (median) | 392.6 (375.0) (n = 24) | 383.7 (358.0) (n = 160) | 0.8 |
Missed at least one dose of anti-TB treatment | 7 (7.2%) | - | - |
Missed at least one dose of ART | 3(3.1) | 7 (1.5%) | 0.535 |
Lost to follow-up | 27(21%) | 10 (2.2%) | 0.000 |